Immuron (IMRN) EBITDA (2016 - 2024)
Immuron (IMRN) recorded quarterly EBITDA of $1660259127.7 billion in Q4 2024, up 80254566798273.6% quarter-over-quarter from $2.1 million in Q4 2023, and up 80254566798273.6% on a YoY basis from N/an in Q1 2024.
Immuron (IMRN) EBITDA (2016 - 2024) Analysis & Trends
Immuron's EBITDA history runs 9 years deep, the most recent figure standing at $1660259127.7 billion for Q4 2024.
- In Q4 2024, EBITDA rose 80254566798273.6% year-over-year to $1660259127.7 billion; the TTM figure through Dec 2024 stood at $1660259127.7 billion (up 59404062924833.59% YoY), while the FY2025 annual figure was -$3.4 million, up 9.08% from the prior year.
- EBITDA was $1660259127.7 billion for Q4 2024 at Immuron, up from $2.1 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $1660259127.7 billion in Q4 2024 to a low of -$1.2 million in Q2 2023.
- Historically, EBITDA has averaged $237179875.4 billion across 5 years, with a median of $2.0 million in 2022.
- The sharpest annual moves came in 2020 and 2024: EBITDA plunged 272.4% in 2020, then soared 80254566798273.6% in 2024.
- A 5-year view of EBITDA shows it stood at -$57538.3 in 2020, then surged by 76.96% to -$13256.7 in 2021, then jumped by 15029.93% to $2.0 million in 2022, then gained by 4.52% to $2.1 million in 2023, then jumped by 80254566798273.6% to $1660259127.7 billion in 2024.
- The last three EBITDA figures came in at $1660259127.7 billion (Q4 2024), $2.1 million (Q4 2023), and $2.4 million (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,660,259,127.73 Bn |
| Dec 31, 2023 | 2.07 Mn |
| Sep 28, 2023 | 2.43 Mn |
| Jun 30, 2023 | -1.24 Mn |
| Dec 31, 2022 | 1.98 Mn |
| Dec 31, 2021 | -13,256.74 |
| Dec 31, 2020 | -57,538.29 |
| Dec 31, 2019 | -15,450.84 |
| Dec 31, 2018 | 1.69 Mn |
| Dec 31, 2017 | -1.45 Mn |
| Dec 31, 2016 | -2.60 Mn |
| Jun 30, 2016 | -3.28 Mn |